Search results
Dr Min-Han Tan is the Founder, CEO and Medical Director of Lucence. The Company develops advanced liquid biopsy blood tests that profile the hallmarks of cancer to the deepest limit to achieve timely tailored treatment and earlier detection. Headquartered in Palo Alto and Singapore, with ofices in Hong Kong and Suzhou, its clinical services are ...
May 9, 2023 · Lucence CEO and Medical Director Dr. Min-Han Tan said, “We’re honored by DPM Heng’s visit and the opportunity to showcase Lucence’s launch of LucenceINSIGHT™ and our U.S. growth. Our mission is early cancer detection through a single blood test, when cancer is most treatable hopefully for cure.
People also ask
Who is Dr Min-Han Tan?
What is Dr Tan known for?
Where did Dr Tan get his medical degree?
May 9, 2023 · Lucence was founded in 2016 in Singapore by CEO Dr. Min-Han Tan as a spin-off from Singapore’s Agency for Science, Technology and Research (A*STAR) and has since grown into a leading global ...
Journal of clinical pathology, jclinpath-2011-200368. , 2011. 334. 2011. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. MH Tan, C Morrison, P Wang, X Yang, CJ Haven, C Zhang, P Zhao, ... Clinical cancer research 10 (19), 6629-6637.
Dr. Min-Han Tan is the Founder, CEO and Medical Director of Lucence. The Company develops advanced liquid biopsy blood tests that profile the hallmarks of cancer to the deepest limit for timely tailored treatment and earlier detection.
Dr. Min-Han Tan, Founder and CEO of Lucence, talks to WIPO Magazine about his company’s commitment to saving the lives of cancer patients around the world through earlier detection of the disease. The earlier cancer is detected, the less invasive and the less painful treatments are going to be. One in three people will get cancer in their ...
